An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway

被引:118
作者
Paine, C [1 ]
Sharlow, E [1 ]
Liebel, F [1 ]
Eisinger, M [1 ]
Shapiro, S [1 ]
Seiberg, M [1 ]
机构
[1] J&J CPWW, Skin Res Ctr, Skillman, NJ 08558 USA
关键词
keratinocyte; melanocyte; skin lightening; soymilk; STI;
D O I
10.1046/j.1523-1747.2001.01291.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The protease-activated receptor 2, expressed on keratinocytes but not on melanocytes, has been ascribed functional importance in the regulation of pigmentation by phagocytosis of melanosomes. Inhibition of protease-activated receptor 2 activation by synthetic serine protease inhibitors requires keratinocyte-melanocyte contact and results in depigmentation of the dark skinned Yucatan swine, suggesting a new class of depigmenting mechanism and agents. We therefore examined natural agents that could exert their effect via the protease-activated receptor 2 pathway. Here we show that soymilk and the soybean-derived serine protease inhibitors soybean trypsin inhibitor and Bowman-Birk inhibitor inhibit protease-activated receptor 2 cleavage, affect cytoskeletal and cell. surface organization, and reduce keratinocyte phagocytosis. The depigmenting activity of these agents and their capability to prevent ultraviolet-induced pigmentation are demonstrated both in vitro and in vivo. These results imply that inhibition of the protease-activated receptor 2 pathway by soymilk may be used as a natural alternative to skin lightening.
引用
收藏
页码:587 / 595
页数:9
相关论文
共 39 条
[1]  
Anderson JW, 1999, AM J CLIN NUTR, V70, p464S, DOI 10.1093/ajcn/70.3.464s
[2]   A GROWTH-REGULATED PROTEASE ACTIVITY THAT IS INHIBITED BY THE ANTICARCINOGENIC BOWMAN-BIRK PROTEASE INHIBITOR [J].
BILLINGS, PC ;
HABRES, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :3120-3124
[3]   THE BOWMAN-BIRK INHIBITOR - TRYPSIN-INHIBITOR AND CHYMOTRYPSIN-INHIBITOR FROM SOYBEANS [J].
BIRK, Y .
INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1985, 25 (02) :113-131
[4]  
Bohm SK, 1996, BIOCHEM J, V314, P1009
[5]   Potent thrombin inhibitors that probe the S-1' subsite: Tripeptide transition state analogues based on a heterocycle-activated carbonyl group [J].
Costanzo, MJ ;
Maryanoff, BE ;
Hecker, LR ;
Schott, MR ;
Yabut, SC ;
Zhang, HC ;
AndradeGordon, P ;
Kauffman, JA ;
Lewis, JM ;
Krishnan, R ;
Tulinsky, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) :3039-3043
[6]   Proteinase-activated receptors:: a growing family of heptahelical receptors for thrombin, trypsin and tryptase [J].
Dáry, O ;
Bunnett, NW .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1999, 27 (02) :246-254
[7]  
Derian CK, 1997, CELL GROWTH DIFFER, V8, P743
[8]   Proteinase-activated receptors:: novel mechanisms of signaling by serine proteases [J].
Déry, O ;
Corvera, CU ;
Steinhoff, M ;
Bunnett, NW .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (06) :C1429-C1452
[9]  
FLEURY Y, 1992, ACS SYM SER, V507, P98
[10]  
FRAKI JE, 1983, BRIT J DERMATOL, V109, P72